Search

Medtronic PLC

Închisă

SectorSănătate

87.71 2.62

Rezumat

Modificarea prețului

24h

Curent

Minim

85.47

Maxim

88.46

Indicatori cheie

By Trading Economics

Venit

206M

1.5B

Vânzări

-51M

9.8B

P/E

Medie Sector

21.614

47.946

EPS

1.45

Randament dividend

3.3

Marjă de profit

15.16

Angajați

95,000

EBITDA

-682M

2B

Recomandări

By TipRanks

Recomandări

Cumpărare

Prognoză pe 12 luni

+20.25% upside

Dividende

By Acuity

Randament dividend

Medie Sector

3.30%

2.27%

Următoarele câștiguri

17 nov. 2026

Data viitoare de dividende

16 oct. 2026

Următoarea dată ex-dividende

25 dec. 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

-3.5B

113B

Deschiderea anterioară

85.09

Închiderea anterioară

87.71

Sentimentul știrilor

By Acuity

18%

82%

33 / 340 Clasament în Healthcare

Medtronic PLC Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

7 oct. 2026, 22:51 UTC

News

Medtronic PLC announced an exchange ratio of 4.5939 shares of MiniMed Group, Inc. stock for each ordinary share, contributing to a modest gain in after-market trading.

6 oct. 2026, 22:40 UTC

Medtronic PLC is recovering in after-market trading, rising sharply from Tuesday's close and reaching its highest level of the day, despite remaining below its 20-day moving average.

5 oct. 2026, 21:01 UTC

Medtronic PLC traded roughly flat during after-market hours, closing near the lower end of its one-month range and below its 20-day moving average.

3 oct. 2026, 00:00 UTC

Medtronic PLC shares traded modestly higher in after-market hours on Friday, recovering from a brief dip and remaining near the lower end of their one-month trading range.

2 oct. 2026, 23:00 UTC

Medtronic PLC is advancing in after-market trading, showing a modest increase since Friday's close, with significant upward movement shortly after the market reopened.

1 oct. 2026, 22:01 UTC

News

Medtronic PLC shares are higher in after-market trading following the approval of new CPT codes for its Altaviva and Symplicity Spyral devices, effective January 2028.

30 sept. 2026, 23:01 UTC

Medtronic PLC is trading modestly higher in after-market hours, reflecting broader market trends amid positive economic indicators and stronger-than-expected private sector job growth.

29 sept. 2026, 20:02 UTC

Medtronic PLC shares fell sharply today, reversing a trend of higher daily closes, amid unusually high trading volume and broader market trends.

28 sept. 2026, 23:16 UTC

Medtronic PLC is trading slightly lower in after-market hours, remaining below its 20-day moving average and near the lower end of its one-month range.

25 sept. 2026, 23:50 UTC

Medtronic PLC is down in after-market trading, continuing a seven-session trend of lower finishes and remaining significantly below its 20-day moving average.

23 sept. 2026, 20:03 UTC

News

Medtronic PLC shares fell sharply, continuing a downward trend with five consecutive losses, despite solid first-quarter results and raised full-year guidance.

22 sept. 2026, 23:21 UTC

Medtronic PLC is trading modestly higher in after-market hours, stabilizing after an initial decline amid broader market weakness.

21 sept. 2026, 19:46 UTC

News

Medtronic PLC shares fell as the company raised its adjusted profit forecast and reported revenue growth for Q1 fiscal 2027, despite FDA clearance for its LigaSure device.

18 sept. 2026, 23:06 UTC

News

Medtronic PLC raised its fiscal 2027 profit forecast and reported first-quarter revenue of $9.756 billion, exceeding expectations, in after-market trading.

17 sept. 2026, 23:06 UTC

Medtronic PLC is trading modestly higher in after-market hours, remaining near the upper end of its one-month range following Thursday's close.

16 sept. 2026, 23:01 UTC

Event

Medtronic PLC's LigaSure™ RAS Maryland jaw device received FDA clearance, but the stock is modestly lower in after-market trading since Wednesday's close.

15 sept. 2026, 23:01 UTC

Medtronic PLC shares are higher in after-market hours, tracking broader market gains. No specific company news was identified to influence this movement.

14 sept. 2026, 23:06 UTC

Medtronic PLC shares are lower in after-market hours amid a U.S. market decline linked to rising crude oil prices and supply concerns.

11 sept. 2026, 22:52 UTC

Medtronic PLC shares are lower in after-market hours, continuing recent downward momentum and trading below the 20-day moving average.

10 sept. 2026, 23:56 UTC

Medtronic PLC shares are lower in after-market hours, continuing a trend from recent sessions. Volatility marked today's trading, with no specific news identified.

9 sept. 2026, 22:02 UTC

Social Media

Medtronic PLC has been recognized by Morningstar as a top dividend stock, with shares moving higher in after-market trading since Wednesday's close.

8 sept. 2026, 23:01 UTC

Medtronic PLC shares are trading higher in after-market hours, reflecting notable fluctuations during the session and remaining near the upper end of their one-month range.

4 sept. 2026, 23:16 UTC

Shares of Medtronic PLC are higher in after-market hours, despite earlier declines. The stock remains above its 20-day moving average.

3 sept. 2026, 23:01 UTC

Medtronic PLC shares declined in after-market trading, reversing gains from earlier sessions. No specific news was identified to explain the price movement.

2 sept. 2026, 23:06 UTC

Medtronic PLC shares are trading higher in after-market hours, remaining above their 20-day moving average and near the upper end of their one-month trading range.

1 sept. 2026, 23:06 UTC

Medtronic PLC shares declined during after-market hours, showing notable volatility. The price remains above its 20-day moving average and near the one-month range's upper end.

31 aug. 2026, 23:01 UTC

Medtronic PLC shares are higher in after-market trading, positioned about 1.01% above their 20-day moving average. No specific news was identified for the movement.

29 aug. 2026, 00:06 UTC

Medtronic PLC shares advanced in after-market trading, fluctuating amid broader market expectations for interest rate hikes and ongoing inflation concerns.

28 aug. 2026, 23:01 UTC

Medtronic PLC shares are higher in after-market trading, with no specific news identified. The stock remains above its 20-day moving average.

27 aug. 2026, 23:02 UTC

Medtronic PLC shares advanced in after-market trading, recovering from earlier volatility. Broader market context includes a decline in initial jobless claims.

Comparație

Modificare preț

Medtronic PLC Așteptări

Obiectiv de preț

By TipRanks

20.25% sus

Prognoză pe 12 luni

Medie 102.824 USD  20.25%

Maxim 118 USD

Minim 85 USD

În baza a 20 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruMedtronic PLC - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

20 ratings

11

Cumpărare

9

Păstrare

0

Vânzare

Sentiment

By Acuity

33 / 340 Clasament în Sănătate

Sentimentul știrilor

Evidențe foarte puternice de creștere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Sub medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Medtronic PLC

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. The segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists; and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat other non-exclusive diseases and conditions; and patient monitoring and airway management products. The Diabetes Operating Unit segment provides insulin pumps and consumables, continuous glucose monitoring systems, and InPen, a smart insulin pen system. The company was founded in 1949 and is headquartered in Galway, Ireland.